# CoreTissue BioEngineering

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/coretissue-bioengineering

- Industry: Medical Devices & Equipment
- Headquarters: Yokohama-shi, Japan
- Website: www.coretissue.com
- Total disclosed funding: $4M
- Latest round: Series A (Feb 24, 2023)
- Investors on record: 6

## About

CoreTissue BioEngineering Inc. is a Japan-based company specializing in tissue-engineered solutions for ligament reconstruction, particularly for anterior cruciate ligament (ACL) surgeries, to enhance recovery for athletes.Founded in 2016, CoreTissue BioEngineering Inc. is based in Yokohama-shi, Japan, and focuses on the development of advanced medical devices for ligament reconstruction. The company has completed three funding deals to date, with the most recent in November 2025, where CoreTissue BioEngineering Inc.raised an undisclosed amount in venture capital from new investor Nippon Ham. The current CEO is Chiaki Waki .CoreTissue BioEngineering Inc. specializes in developing tissue-engineered ligaments designed for anterior cruciate ligament (ACL) reconstruction. Their proprietary decellularization technology regenerates damaged tissues, aiding recovery for athletes. The products are marketed to healthcare providers in Japan and other regions, focusing on improving surgical outcomes in orthopedic procedures.CoreTissue BioEngineering generates revenue from the sales of its medical devices for ligament reconstruction through direct B2B transactions with healthcare institutions. Their innovative solutions are offered through partnerships with hospitals and orthopedic clinics, ensuring access to the latest tissue-engineered advancements for surgical applications.In November 2025, CoreTissue BioEngineering Inc. raised an undisclosed amount in venture capital from new investor Nippon Ham. The company plans to leverage this funding to enhance its product offerings and expand its market presence.

## Funding rounds

- Series A, Feb 24, 2023, $4M — AXA Life Japan, WERU INVESTMENT, Japan Science and Technology Agency, KSP, Teijin, Sun Global Co.

## Investors

- AXA Life Japan — Series A
- WERU INVESTMENT (https://capitalatlas.ai/funds/weru-investment) — Series A
- Japan Science and Technology Agency — Series A
- KSP (https://capitalatlas.ai/funds/ksp) — Series A
- Teijin — Series A
- Sun Global Co. — Series A